STING-IN-2 (C-170) is an experimental drug which acts as an irreversible antagonist of the stimulator of interferon genes (STING) protein. It has antiinflammatory, antiviral and potential anti-cancer effects by reducing cytokine signalling, and has potential application in numerous disease states in which inflammation plays a role.
See also H-151 SN-011
References